Literature DB >> 8344103

Alpha-smooth-muscle actin expression in normal and fibrotic human livers.

K Yamaoka1, T Nouchi, F Marumo, C Sato.   

Abstract

To determine the significance of the expression of alpha-smooth-muscle actin in the fibrotic human liver, normal and diseased livers were stained with anti-alpha-smooth-muscle-actin antibody by an immunoperoxidase method. Vitamin A-containing lipocytes were also identified by the modified Kupffer's gold chloride method. In the normal human liver, lipocytes as well as vascular smooth muscle cells expressed alpha-smooth-muscle actin. In alcoholic liver disease, there was an increase in the cells positive for alpha-smooth-muscle actin adjacent to the fibrotic areas, but the response of lipocytes to the gold chloride reaction diminished. In chronic hepatitis, the cells positive for alpha-smooth-muscle actin increased around the enlarged portal areas, and the response to the gold chloride reaction did not change appreciably. An increase in the cells positive for alpha-smooth-muscle actin was associated with the progression of hepatic fibrosis in the liver of patients with alcoholic liver disease and chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344103     DOI: 10.1007/bf01308606

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis.

Authors:  T Nouchi; Y Tanaka; T Tsukada; C Sato; F Marumo
Journal:  Liver       Date:  1991-04

2.  Ultrastructure of initial stages of perivenular fibrosis in alcohol-fed baboons.

Authors:  M Nakano; C S Lieber
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

3.  Nonparenchymal cells cultivated from explants of fibrotic liver resemble endothelial and smooth muscle cells from blood vessel walls.

Authors:  B Voss; J Rauterberg; G Pott; U Brehmer; S Allam; R Lehmann; D B von Bassewitz
Journal:  Hepatology       Date:  1982 Jan-Feb       Impact factor: 17.425

4.  Hepatic vitamin A depletion in alcoholic liver injury.

Authors:  M A Leo; C S Lieber
Journal:  N Engl J Med       Date:  1982-09-02       Impact factor: 91.245

5.  Reduced retinoid content in hepatocellular carcinoma with special reference to alcohol consumption.

Authors:  S Adachi; H Moriwaki; Y Muto; Y Yamada; Y Fukutomi; M Shimazaki; M Okuno; M Ninomiya
Journal:  Hepatology       Date:  1991-11       Impact factor: 17.425

6.  Lipocytes and transitional cells in alcoholic liver disease: a morphometric study.

Authors:  K M Mak; C S Lieber
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

7.  Contractile fibroblasts in chronic alcoholic cirrhosis.

Authors:  R Rudolph; W J McClure; M Woodward
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

8.  Phenotypic modulation in lipocytes in experimental liver fibrosis.

Authors:  Y Tanaka; T Nouchi; M Yamane; T Irie; H Miyakawa; C Sato; F Marumo
Journal:  J Pathol       Date:  1991-07       Impact factor: 7.996

9.  The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease.

Authors:  Y Minato; Y Hasumura; J Takeuchi
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

10.  Immunocytochemical detection of desmin in fat-storing cells (Ito cells).

Authors:  Y Yokoi; T Namihisa; H Kuroda; I Komatsu; A Miyazaki; S Watanabe; K Usui
Journal:  Hepatology       Date:  1984 Jul-Aug       Impact factor: 17.425

View more
  25 in total

1.  Immunohistochemical study for the origin of ductular reaction in chronic liver disease.

Authors:  Sun-Jae Lee; Jae-Bok Park; Kyung-Hyun Kim; Woo-Ram Lee; Jung-Yeon Kim; Hyun-Jin An; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 2.  Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.

Authors:  Sun-Jae Lee; Kyung-Hyun Kim; Kwan-Kyu Park
Journal:  World J Hepatol       Date:  2014-04-27

Review 3.  Human hepatic stellate cell isolation and characterization.

Authors:  Linshan Shang; Mojgan Hosseini; Xiao Liu; Tatiana Kisseleva; David Allen Brenner
Journal:  J Gastroenterol       Date:  2017-11-01       Impact factor: 7.527

Review 4.  The hepatic stellate (Ito) cell: its role in human liver disease.

Authors:  M L Hautekeete; A Geerts
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

5.  The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow?

Authors:  Rebecca G Wells
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

6.  Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver.

Authors:  H Enzan; H Himeno; S Iwamura; T Saibara; S Onishi; Y Yamamoto; H Hara
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis.

Authors:  H Enzan; H Himeno; S Iwamura; T Saibara; S Onishi; Y Yamamoto; E Miyazaki; H Hara
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 8.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

9.  Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver.

Authors:  Elke Van Rossen; Sara Vander Borght; Leo Adrianus van Grunsven; Hendrik Reynaert; Veerle Bruggeman; Rune Blomhoff; Tania Roskams; Albert Geerts
Journal:  Histochem Cell Biol       Date:  2008-12-04       Impact factor: 4.304

10.  An amphipathic alpha-helical peptide from apolipoprotein A1 stabilizes protein polymer vesicles.

Authors:  Martha K Pastuszka; Xiangdong Wang; Lye Lin Lock; Siti Mohd Janib; Honggang Cui; Laurie D DeLeve; J Andrew MacKay
Journal:  J Control Release       Date:  2014-07-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.